Financial statements Implon Laboratories

Balance sheet of Implon Laboratories

Company age:
Age:
7 y. 3 m. 26 d.
Share capital:
Share capital:
20 000 PLN

Balance sheet data of IMPLON LABORATORIES

Year
2018
2020
2021
2022
2023
Total assets 415 695,41 57 455,62 364 108,27 2 513 196,92 241 913,35
A. Fixed assets 0,00 0,00 0,00 350 094,12 33 423,66
B. Current assets 415 695,41 57 455,62 364 108,27 2 163 102,80 208 489,69
C. Share capital contributions (basic funds) 0,00 0,00 0,00 - -
D. Own shares (stocks) 0,00 0,00 0,00 - -
Total liabilities 415 695,41 57 455,62 364 108,27 2 513 196,92 241 913,35
A. Equity -28 852,26 -295 387,63 36 245,51 -836 281,32 -2 207 835,38
B. Liabilities and provisions for liabilities 444 547,67 352 843,25 327 862,76 3 349 478,24 2 449 748,73
I. Long-term liabilities 0,00 238 000,00 237 801,75 1 348 693,17 2 120 406,55
II. Short-term liabilities 444 547,67 114 843,25 90 061,01 537 542,18 329 342,18
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.